14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.85 $4.97 Tuesday, 23rd Apr 2024 ALDX stock ended at $3.91. This is 0.509% less than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 7.20% from a day low at $3.89 to a day high of $4.17.
90 days $2.71 $4.97
52 weeks $1.42 $11.97

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
Mar 24, 2021 $11.47 $11.66 $10.57 $10.65 829 132
Mar 23, 2021 $12.09 $12.29 $11.46 $11.49 763 957
Mar 22, 2021 $12.02 $12.55 $11.68 $12.24 613 476
Mar 19, 2021 $11.62 $12.12 $11.58 $11.98 4 200 342
Mar 18, 2021 $12.24 $12.39 $11.40 $11.61 799 124
Mar 17, 2021 $11.48 $12.33 $11.42 $12.33 629 596
Mar 16, 2021 $12.08 $12.26 $11.43 $11.71 454 787
Mar 15, 2021 $12.44 $13.09 $11.79 $11.98 824 467
Mar 12, 2021 $12.00 $12.63 $11.86 $12.52 714 931
Mar 11, 2021 $11.86 $12.16 $11.72 $12.07 592 733
Mar 10, 2021 $11.66 $12.14 $11.41 $12.08 452 902
Mar 09, 2021 $10.75 $11.86 $10.69 $11.62 433 935
Mar 08, 2021 $11.01 $11.38 $10.62 $10.66 435 440
Mar 05, 2021 $11.09 $11.24 $9.90 $11.18 1 230 335
Mar 04, 2021 $11.79 $12.12 $10.76 $11.17 772 451
Mar 03, 2021 $12.32 $12.60 $11.71 $11.91 551 617
Mar 02, 2021 $12.30 $12.50 $11.80 $12.43 612 312
Mar 01, 2021 $12.39 $12.83 $11.94 $12.20 513 933
Feb 26, 2021 $11.69 $12.33 $11.35 $12.26 512 656
Feb 25, 2021 $12.11 $12.33 $11.48 $11.70 626 710
Feb 24, 2021 $12.01 $12.58 $11.55 $12.22 711 048
Feb 23, 2021 $11.74 $11.75 $10.55 $11.38 950 423
Feb 22, 2021 $12.54 $13.07 $12.08 $12.19 592 362
Feb 19, 2021 $12.64 $13.35 $12.52 $12.75 604 154
Feb 18, 2021 $13.32 $13.49 $12.20 $12.35 1 009 047
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT